Compendium of pharmaceuticals and specialties. Ottawa: L.D. Bruce, 1997:544–5.
2.
HeykantsJWynantsJScheijgrondH. The absorption, excretion and metabolism of levamisole in man. Unpublished (clinical research report no. R12564/32). Janssen Pharmaceutica, 1975.
3.
EngelmanGLRichardsonAG. Effects of levamisole on primary cultures of adult rat hepatocytes. Biochem Pharmacol1986;35:1547–54.
4.
GriffithHW. Complete guide to prescription and nonprescription drugs. New York: The Putnam Berkeley Group, 1996.
5.
FigueredoATFawcetSEMolloyDWDobranowskiJPaulsethJE. Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: A report of two cases. Cancer Invest1995;13:608–11.
6.
HookCCKimmelDWKvolsLKScheithauerBWForsythPARubinJMultifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol1992;31:262–7.